153 related articles for article (PubMed ID: 26679247)
21. Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudine-resistant HBV.
Wang J; Liu J; Qi C; Yan T; Cao F; Jin L; He Y; Yang Y; Zhang S; Chen T; Zhao Y
Antivir Ther; 2015; 20(7):681-7. PubMed ID: 26215771
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous quantification of four antiretroviral drugs in breast milk samples from HIV-positive women by an ultra-high performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method.
Ramírez-Ramírez A; Sánchez-Serrano E; Loaiza-Flores G; Plazola-Camacho N; Rodríguez-Delgado RG; Figueroa-Damián R; Domínguez-Castro M; López-Martínez M; Flores-García Z; Hernández-Pineda J
PLoS One; 2018; 13(1):e0191236. PubMed ID: 29351333
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus mother-to-child transmission among HIV-infected women receiving lamivudine-containing antiretroviral regimens during pregnancy and breastfeeding.
Pirillo MF; Scarcella P; Andreotti M; Jere H; Buonomo E; Sagno JB; Amici R; Mancini MG; Leone P; Ceffa S; Mancinelli S; Marazzi MC; Vella S; Palombi L; Giuliano M
J Viral Hepat; 2015 Mar; 22(3):289-96. PubMed ID: 25174900
[TBL] [Abstract][Full Text] [Related]
24. Viro-immunological response and emergence of resistance in HIV-infected women receiving combination antiretroviral regimens for the prevention of mother-to-child transmission in Malawi.
Palombi L; Galluzzo CM; Pirillo MF; Liotta G; Andreotti M; Jere H; Sagno JB; Luhanga R; Mancinelli S; Ceffa S; Amici R; Marazzi MC; Vella S; Giuliano M
J Antimicrob Chemother; 2014 Mar; 69(3):749-52. PubMed ID: 24135952
[TBL] [Abstract][Full Text] [Related]
25. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
[TBL] [Abstract][Full Text] [Related]
26. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
[TBL] [Abstract][Full Text] [Related]
27. Nevirapine, sodium concentration and HIV-1 RNA in breast milk and plasma among HIV-infected women receiving short-course antiretroviral prophylaxis.
Salado-Rasmussen K; Theilgaard ZP; Chiduo MG; Bygbjerg IC; Gerstoft J; Lüneborg-Nielsen M; Lemnge M; Katzenstein TL
PLoS One; 2015; 10(3):e0121111. PubMed ID: 25812161
[TBL] [Abstract][Full Text] [Related]
28. Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.
Gallant JE; DeJesus E; Arribas JR; Pozniak AL; Gazzard B; Campo RE; Lu B; McColl D; Chuck S; Enejosa J; Toole JJ; Cheng AK;
N Engl J Med; 2006 Jan; 354(3):251-60. PubMed ID: 16421366
[TBL] [Abstract][Full Text] [Related]
29. Prevention of mother-to-child HIV-1 transmission in Burkina Faso: evaluation of vertical transmission by PCR, molecular characterization of subtypes and determination of antiretroviral drugs resistance.
Sagna T; Bisseye C; Compaore TR; Kagone TS; Djigma FW; Ouermi D; Pirkle CM; Zeba MT; Bazie VJ; Douamba Z; Moret R; Pietra V; Koama A; Gnoula C; Sia JD; Nikiema JB; Simpore J
Glob Health Action; 2015; 8():26065. PubMed ID: 25630709
[TBL] [Abstract][Full Text] [Related]
30. Meconium Tenofovir Concentrations and Growth and Bone Outcomes in Prenatally Tenofovir Exposed HIV-Uninfected Children.
Himes SK; Wu JW; Jacobson DL; Tassiopoulos K; Hazra R; Kacanek D; Van Dyke RB; Rich KC; Siberry GK; Huestis MA;
Pediatr Infect Dis J; 2015 Aug; 34(8):851-7. PubMed ID: 25961889
[TBL] [Abstract][Full Text] [Related]
31. Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment.
Shapiro RL; Holland DT; Capparelli E; Lockman S; Thior I; Wester C; Stevens L; Peter T; Essex M; Connor JD; Mirochnick M
J Infect Dis; 2005 Sep; 192(5):720-7. PubMed ID: 16088821
[TBL] [Abstract][Full Text] [Related]
32. Growth indices in breastfed infants pre and postnatally exposed to tenofovir compared with tenofovir-unexposed infants.
Liotta G; Floridia M; Andreotti M; Jere H; Sagno JB; Marazzi MC; Buonomo E; Scarcella P; Mancinelli S; Vella S; Giuliano M; Palombi L
AIDS; 2016 Jan; 30(3):525-7. PubMed ID: 26765942
[TBL] [Abstract][Full Text] [Related]
33. Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study.
Hosseinipour M; Nelson JAE; Trapence C; Rutstein SE; Kasende F; Kayoyo V; Kaunda-Khangamwa B; Compliment K; Stanley C; Cataldo F; van Lettow M; Rosenberg NE; Tweya H; Gugsa S; Sampathkumar V; Schouten E; Eliya M; Chimbwandira F; Chiwaula L; Kapito-Tembo A; Phiri S;
J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2(Suppl 2):S149-S155. PubMed ID: 28498184
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness and safety of simplification therapy with once-daily tenofovir, lamivudine, and efavirenz in HIV-1-infected patients with undetectable plasma viral load on HAART.
Arrizabalaga J; Arazo P; Aguirrebengoa K; García-Palomo D; Chocarro A; Labarga P; Muñoz-Sánchez MJ; Echevarría S; Oteo JA; Uriz J; Letona S; Fariñas MC; Peralta G; Pinilla J; Ferrer P; Alvarez ML; Iribarren JA
HIV Clin Trials; 2007; 8(5):328-36. PubMed ID: 17956834
[TBL] [Abstract][Full Text] [Related]
35. Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine.
Havlir DV; Koelsch KK; Strain MC; Margot N; Lu B; Ignacio CC; Miller MD; Wong JK;
J Infect Dis; 2005 Apr; 191(7):1164-8. PubMed ID: 15747253
[TBL] [Abstract][Full Text] [Related]
36. Efavirenz in human breast milk, mothers', and newborns' plasma.
Schneider S; Peltier A; Gras A; Arendt V; Karasi-Omes C; Mujawamariwa A; Ndimubanzi PC; Ndayisaba G; Wennig R
J Acquir Immune Defic Syndr; 2008 Aug; 48(4):450-4. PubMed ID: 18614925
[TBL] [Abstract][Full Text] [Related]
37. Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy.
Kakehasi FM; Tupinambás U; Cleto S; Aleixo A; Lin E; Melo VH; Aguiar RA; Pinto JA
AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1515-20. PubMed ID: 18160009
[TBL] [Abstract][Full Text] [Related]
38. Elective cesarean delivery plus short-course lamivudine and zidovudine for the prevention of mother-to-child transmission of human immunodeficiency virus type 1.
Panburana P; Sirinavin S; Phuapradit W; Vibhagool A; Chantratita W
Am J Obstet Gynecol; 2004 Mar; 190(3):803-8. PubMed ID: 15042018
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.
Gallant JE; Staszewski S; Pozniak AL; DeJesus E; Suleiman JM; Miller MD; Coakley DF; Lu B; Toole JJ; Cheng AK;
JAMA; 2004 Jul; 292(2):191-201. PubMed ID: 15249568
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus infection and pregnancy.
Pol S; Corouge M; Fontaine H
Clin Res Hepatol Gastroenterol; 2011 Oct; 35(10):618-22. PubMed ID: 21659015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
